p38γ is essential for cell cycle progression and liver tumorigenesis-Reference-Cited by-同舟云学术

p38γ is essential for cell cycle progression and liver tumorigenesis

Published:2019-04 Issue:7753 Volume:568 Page:557-560
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Tomás-Loba Antonia,Manieri Elisa,González-Terán Bárbara,Mora Alfonso,Leiva-Vega Luis,Santamans Ayelén M.,Romero-Becerra Rafael,Rodríguez Elena,Pintor-Chocano Aránzazu,Feixas Ferran,López Juan Antonio,Caballero Beatriz,Trakala Marianna,Blanco Óscar,Torres Jorge L.,Hernández-Cosido Lourdes,Montalvo-Romeral Valle,Matesanz Nuria,Roche-Molina Marta,Bernal Juan Antonio,Mischo Hannah,León Marta,Caballero Ainoa,Miranda-Saavedra Diego,Ruiz-Cabello Jesús,Nevzorova Yulia A.,Cubero Francisco Javier,Bravo Jerónimo,Vázquez Jesús,Malumbres Marcos,Marcos Miguel,Osuna Sílvia,Sabio Guadalupe

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1112-8.pdf

Reference29 articles.

1. Malumbres, M. Cyclin-dependent kinases. Genome Biol. 15, 122 (2014).

2. Varjosalo, M. et al. The protein interaction landscape of the human CMGC kinase group. Cell Rep. 3, 1306–1320 (2013).

3. Malumbres, M. & Barbacid, M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9, 153–166 (2009).

4. Canhoto, A. J., Chestukhin, A., Litovchick, L. & DeCaprio, J. A. Phosphorylation of the retinoblastoma-related protein p130 in growth-arrested cells. Oncogene 19, 5116–5122 (2000).

5. Mayhew, C. N. et al. Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy. Cancer Res. 65, 4568–4577 (2005).

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LOC730101 transmitted by exosomes facilitates laryngeal squamous cell carcinoma tumorigenesis via regulation of p38 MAPK gamma;Cellular Signalling;2024-10

2. A first-in-kind MAPK13 inhibitor that can correct stem cell reprogramming and post-injury disease;2024-08-22

3. CDKL3 is a targetable regulator of cell cycle progression in cancers;Journal of Clinical Investigation;2024-07-04

4. MAPK13 controls structural remodeling and disease after epithelial injury;2024-06-03

5. A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B-cell lymphoma;Clinical and Translational Oncology;2024-05-21